News of positive data from Moderna’s (Cambridge, MA) Phase I trial of a COVID-19 vaccine has dominated this week’s headlines. Their vaccine is an mRNA-based vaccine—an entirely new approach to not only vaccines but also to therapeutics. mRNA-based drugs...
World AIDS Day: Understanding HIV December 1 marked World AIDS Day, an international day dedicated to raising awareness of the AIDS pandemic caused by the spread of human immunodeficiency virus (HIV) infection. According to UNAIDS, 37.9 million people globally were...
The Latest On The Rise Of Zika The spread of the Zika virus is raising alarm bells in the United States, and Congress has yet to pass any legislation to combat the fight. Zika infections reported in Miami confirm the virus’ stateside arrival, pushing residents to take...
Antagonists Fight A Good Fight Small molecule inhibitors, also known as antagonists in the industry, fight a good fight. In fact, many drugs on the market today work by inhibiting overactive, disease-associated proteins. Novartis’ (Basel, Switzerland) top...
THE ROOT OF DUCHENNE MUSCULAR DYSTROPHY World Duchenne Awareness Day called attention to Duchenne Muscular Dystrophy (DMD) this past Monday. Affecting one in 3,500 newborn baby boys worldwide, this fatal disease is caused by a mutation in the gene that codes for the...
From startups to the Fortune 500, we train employees at companies of all sizes. We offer customized, in-house courses and open enrollment classes. Visit Biotech Primer for more information.
